Cargando…
Sleep architecture and cognitive changes in olanzapine-treated patients with depression: A double blind randomized placebo controlled trial
BACKGROUND: Disturbance in sleep quality is a symptom of Major Depressive Disorder (MDD) and Bipolar Disorder (BD) and thus improving quality of sleep is an important aspect of successful treatment. Here, a prospective, double-blind, randomized, placebo-controlled study examined the effect of olanza...
Autores principales: | Lazowski, Lauren K, Townsend, Ben, Hawken, Emily R, Jokic, Ruzica, du Toit, Regina, Milev, Roumen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223523/ https://www.ncbi.nlm.nih.gov/pubmed/25030264 http://dx.doi.org/10.1186/1471-244X-14-202 |
Ejemplares similares
-
Effects of quetiapine on sleep architecture in patients with unipolar or bipolar depression
por: Gedge, Laura, et al.
Publicado: (2010) -
Repetitive transcranial magnetic stimulation for treatment of elderly patients with depression – an open label trial
por: Abraham, Gaby, et al.
Publicado: (2007) -
Effects of Electroconvulsive Therapy and Repetitive Transcranial Magnetic Stimulation on Serum Brain-Derived Neurotrophic Factor Levels in Patients with Depression
por: Gedge, Laura, et al.
Publicado: (2012) -
Neurocognition and Depressive Symptoms have Unique Pathways to
Predicting Different Domains of Functioning in Major Depressive
Disorder
por: Wood-Ross, Chelsea, et al.
Publicado: (2022) -
The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study
por: Chinna Meyyappan, Arthi, et al.
Publicado: (2021)